Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of James (Jamie) Levine as chief financial officer.
| less than a minute read
Cidara Therapeutics Appoints James Levine as CFO
Get in touch
Get in touch
“I am confident that Jamie’s diverse background in finance and experience on Wall Street, as well as Jessica’s breadth of legal experience in clinical development through to commercialization, will be tremendous assets to our company.” - Jeffrey Stein, Ph.D., president and chief executive officer of Cidara
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-18-23-13-222-6a722e11663e81e26a6b2c3e.jpg)
